John Craighead

@GrailBio @Atarabio @Sanofi @SanofiGenzyme @IAmBiotech (BIO), HGS and Lehman biotech analyst alum. Tweets are mine

[John Craighead @john_craighead]

I'm excited to join Elpiscience Biopharmaceuticals as CFO to support the company’s robust pipeline of innovative cancer immunotherapies and mission to transform the lives of patients suffering from cancer https://t.co/ZBC6xzRspT

[John Craighead @john_craighead]

Excited to share @US_FDA has cleared @Elpiscience's ES014 IND to initiate Ph1 study. ES014 is a novel anti-#CD39-#TGFbeta bispecific antibody targeting two major #tumormicroenvironment immunosuppressive mechanisms #adenosine #immunooncology #ChinaBiotech https://t.co/1tZzZWrlaA

[John Craighead @john_craighead]

Congratulations @Elpiscience partner $CMPX on positive interim ES104 Ph2 data in combo w/ paclitaxel in #BiliaryTractCancer. Excited to progress this potential new option for #ColorectalCancer, #CholangioCarcinoma and #GastricCancer patients in China https://t.co/quHJUG4aMO

[nature @Nature]

The quest to prevent MS — and understand other post-viral diseases https://t.co/Unj3VhdUMH

[John Craighead @john_craighead]

We are excited to initiate this @Elpiscience DLL4-VEGF bispecific antibody Ph1/2 study. In Ph1 ES104 showed encouraging single-agent activity in advanced #ColorectalCancer and #GastricCancer patients resistant to anti-VEGF #clinicaltrials #ChinaBiotech https://t.co/fEgQYVVy0a

[John Craighead @john_craighead]

Great news for cancer patients worldwide with Elpiscience #CD39 mAb IND clearance in China, which follows the recent Phase I clinical study initiation in the US! #oncology #adenosine #ChinaBiotech #immunooncology #clinicaltrials
https://t.co/CEpzFyfQ35

[John Craighead @john_craighead]

Exciting clinical progress for patients! #Elpiscience #immunotherapy #oncology
https://t.co/UXuRKERGXU

[Harvard University @Harvard]

“This is a big step because it suggests that most MS cases could be prevented by stopping EBV infection, and that targeting EBV could lead to the discovery of a cure for MS.” https://t.co/IQqYNo4dE4

[STAT @statnews]

Researchers have found strong new evidence that suggests a virus triggers multiple sclerosis https://t.co/ZhbibWT48C

[The New York Times @nytimes]

Researchers have found what some say is the most compelling evidence that people infected with Epstein-Barr, an exceedingly common virus, may be more likely to develop multiple sclerosis, a neurological illness. https://t.co/3u7t9jdy3D

[Eric Feigl-Ding @DrEricDing]

💡HUGE—We now have evidence that Multiple Sclerosis is likely caused by an infection—notably, the Epstein-Barr virus increased risk of developing MS by a whopping **32-fold***—via Harvard epidemiology team. ➡️ Hopeful because EBV vaccine coming soon. 🧵
https://t.co/pdHsFXXyui

[News from Science @NewsfromScience]

Scientists hope a new study—which strongly links multiple sclerosis with Epstein-Barr virus—will spur the development of a vaccine against #EBV. https://t.co/n2xhI1t8qJ

[John Craighead @john_craighead]

Excellent study! #EBV #MultipleSclerosis #MS #MSResearch

[Harvard T.H. Chan School of Public Health @HarvardChanSPH]

“The hypothesis that EBV causes MS has been investigated by our group and others for several years, but this is the first study providing compelling evidence of causality,” said Harvard Chan School's Alberto Ascherio, senior author of the study. https://t.co/rdHomOQDgJ

[Laurie Garrett @Laurie_Garrett]

Sickness & death are linked to the dose, or viral load (VL), of #SARSCoV2 in initial infection, according to a NYC study of 6923 #COVID19 patients hosp'ed betwn Mar15-May14, 2020. PCR measurements of VL samps:
- 48% had high VL in March,
- mask + lockdown required, then...
MORE

[GRAIL @GrailBio]

We are pleased that the New York State Department of Health has approved Galleri, our multi-cancer early detection blood test. Healthcare providers in New York can now prescribe Galleri, a first-of-its-kind blood test that can detect multiple cancers early https://t.co/l7bz9ziF5H

[Boris Johnson @BorisJohnson]

Early diagnosis is critical to beating cancer.

The NHS's world-leading trial of a potentially life-saving blood test that detects cancer before symptoms appear could be revolutionary in our battle against a disease that claims the lives of so many.

https://t.co/l1iam7zhF5

[Laurie Garrett @Laurie_Garrett]

Martin Luther, 1527, on religion and the #Plague
“I shall ask God mercifully to protect us. Then I shall fumigate, help purify the air, administer medicine & take it. I shall avoid places & persons where my presence is not needed in order not to become contaminated and..."
MORE

[Mayo Clinic @MayoClinic]

Mayo Clinic recognized the debut of a groundbreaking multi-cancer early detection test called Galleri™ that can detect more than 50 types of cancers through a simple blood draw. Read more: https://t.co/SkuJeFKhuy

[John Craighead @john_craighead]

I'm thrilled to share the @GalleriTest is here! It's an exciting day for GRAILers as we introduce @GrailBio's groundbreaking multi-cancer early detection #MCED blood test. #DetectCancerEarly #Cancer

[GRAIL @GrailBio]

We are proud to announce that @GalleriTest, our multi-cancer early detection blood test, is now available by prescription only. Learn more about the science behind Galleri here: https://t.co/ZKIyLbboZS #DetectCancerEarly

[Cleveland Clinic Urology @CleClinicUro]

@CleClinicMD was proud to partner with @Grailbio and serve as a study site in the development of Galleri, the first-of-kind multi-cancer early detection blood test.

Learn more about how Galleri can help #DetectCancerEarly #CleClinicCancer